InVivo Therapeutics soars 15% on FDA acceptance of preclinical module for HDE submission
14 July 2021 - 1:02AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Apr 2024 to May 2024
InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From May 2023 to May 2024